Track Viveve Medical's operating income ($-21M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022
As of the most recent data (September 2022), VIVE shows a operating income of $-21M. That compares with $-20M in the prior-year period — down 6.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VIVE's operating income is now $-21M (was $-20M) — a 6.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Viveve Medical is outperforming or lagging.
Tracking VIVE's operating income over time shows whether Viveve Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $-20M in the prior-year period — down 6.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Viveve Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-21M) with ownership activity and broader fundamentals.
Viveve Medical's operating income is $-21M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.